Loading...
Loading...
ACADIA Pharmaceuticals Inc.
ACAD
announced Wednesday, the pricing of an underwritten public offering of
10,344,827 shares of its common stock, offered at a price to the public
of $29.00 per share. The gross proceeds from this offering to ACADIA are
expected to be approximately $300.0 million, before deducting
underwriting discounts and commissions and other estimated offering
expenses payable by ACADIA. ACADIA has granted the underwriters a 30-day
option to purchase up to an aggregate of 1,551,724 additional shares of
common stock. The offering is expected to close on or about January 12,
2016, subject to customary closing conditions.
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in